Question 1

What are the potential side effects of the new treatments being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

Question 2

How do the investigational treatments compare to standard chemotherapy in terms of effectiveness?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the expected duration of my participation in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

Question 4

Will I need to undergo any additional tests or procedures during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01) clinical trial (NCT06780085). Contact the study team or your healthcare provider for specific answers.

What this study is about